Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Broussonin E could suppress inflammation by modulating macrophages activation STATe via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis.
Description | Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis. |
Molecular Weight | 288.34 |
Formula | C17H20O4 |
CAS No. | 90902-21-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Broussonin E 90902-21-9 Angiogenesis Apoptosis Chromatin/Epigenetic JAK/STAT signaling MAPK Stem Cells TNF p38 MAPK ERK JAK STAT Inhibitor inhibitor inhibit